9 August 2016 - Legislation to deter brand-name pharmaceutical companies from blocking more affordable generic alternatives has been introduced in the U.S. Senate.

Sen Patrick Leahy (D, Vt) introduced the legislation under the act titled CREATES—Creating and Restoring Equal Access to Equivalent Samples—with Sen Chuck Grassley (R, Iowa), Sen Amy Klobuchar (D, Minn), and Sen Mike Lee (R, Utah).

Read JAMA article